Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Raw Materials (2024 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Raw Materials for 2 consecutive years, with $557000.0 as the latest value for Q4 2025.

  • Quarterly Raw Materials fell 89.6% to $557000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $557000.0 through Dec 2025, down 89.6% year-over-year, with the annual reading at $557000.0 for FY2025, 89.6% down from the prior year.
  • Raw Materials hit $557000.0 in Q4 2025 for Eton Pharmaceuticals, down from $5.4 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $5.4 million in Q4 2024 to a low of $557000.0 in Q4 2025.